Source link : https://newshealth.biz/health-news/fda-eliminates-barrier-to-clozapine-plans-to-end-rems-program/
(MedPage Today) — The FDA no longer expects prescribers, pharmacies, and patients to participate in the risk evaluation and mitigation strategy (REMS) program for the antipsychotic clozapine, the agency announced this week. Following the advice… Source link : https://www.medpagetoday.com/psychiatry/schizophrenia/114380 Author : Publish date : 2025-02-26 15:51:10 Copyright for syndicated content belongs to the linked Source.
Author : News Health
Publish date : 2025-02-26 15:51:10
Copyright for syndicated content belongs to the linked Source.